Numbers Crunched: Reviewing Biopharma's FY 2019 Performance

 
• By Lucie Ellis-Taitt

The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?

Scrip 100 Outlook 2021

More from Business Strategy

More from In Vivo